Public Alert No: 0007/2019 – Falsified ICLUSIG traded globally
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been notified of falsified versions of ICLUSIG 15mg and ICLUSIG 45mg circulating in the WHO Region of Europe and the WHO Region of the Americas. The active pharmaceutical ingredient of the Genuine ICLUSIG is Ponatinib Hydrochloride, which is used to treat […]